 |
Prescription and Over-the-Counter Drug Product List
24th Edition
Cumulative Supplement Number 3:
March 2005
NOTE: The format for the Monthly Additions/Deletions Drug
Product List has changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.5
CUMULATIVE SUPPLEMENT LEGEND.
ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
TABLET; ORAL
>A> ACETAMINOPHEN AND TRAMADOL HCL
>A> AB KALI LABS 325MG;37.5MG N76475 001 Apr 21, 2005 Mar NEWA
ULTRACET
>D> + ORTHO MCNEIL 325MG;37.5MG N21123 001 Aug 15, 2001 Mar CFTG
>A> AB + 325MG;37.5MG N21123 001 Aug 15, 2001 Mar CFTG
ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE
CAPSULE; ORAL
SEMPREX-D
>D> + CELLTECH PHARMS 8MG;60MG N19806 001 Mar 25, 1994 Mar CAHN
>A> + UCB 8MG;60MG N19806 001 Mar 25, 1994 Mar CAHN
ACYCLOVIR
CAPSULE; ORAL
ACYCLOVIR
>D> AB COPLEY PHARM 200MG N74914 001 Nov 26, 1997 Mar CAHN
>A> AB TEVA PHARMS 200MG N74914 001 Nov 26, 1997 Mar CAHN
TABLET; ORAL
ACYCLOVIR
>D> AB COPLEY PHARM 400MG N75021 001 Mar 18, 1998 Mar CAHN
>D> AB 800MG N75021 002 Mar 18, 1998 Mar CAHN
>A> AB TEVA PHARMS 400MG N75021 001 Mar 18, 1998 Mar CAHN
>A> AB 800MG N75021 002 Mar 18, 1998 Mar CAHN
AMANTADINE HYDROCHLORIDE
SYRUP; ORAL
AMANTADINE HCL
>D> AA COPLEY PHARM 50MG/5ML N73115 001 Aug 23, 1991 Mar CAHN
>A> AA TEVA PHARMS 50MG/5ML N73115 001 Aug 23, 1991 Mar CAHN
AMINO ACIDS
INJECTABLE; INJECTION
AMINOSYN 7%
>D> @ HOSPIRA 7% (7GM/100ML) N17673 002 Mar CMFD
>A> 7% (7GM/100ML) N17673 002 Mar CMFD
AMINOSYN 8.5%
>D> @ HOSPIRA 8.5% (8.5GM/100ML) N17673 004 Mar CMFD
>A> 8.5% (8.5GM/100ML) N17673 004 Mar CMFD
AMIODARONE
INJECTABLE; INTRAVENOUS
AMIODARONE HCL
>A> AP APOTEX 50MG/ML N77161 001 Apr 20, 2005 Mar NEWA
AMIODARONE HYDROCHLORIDE
INJECTABLE; INJECTION
AMIODARONE HCL
>D> AP AM PHARM PARTNERS 50MG/ML N75761 001 Oct 15, 2002 Mar CRLD
>A> AP + 50MG/ML N75761 001 Oct 15, 2002 Mar CRLD
>D> AP APOTEX 50MG/ML N76394 001 Apr 25, 2003 Mar CRLD
>A> AP + 50MG/ML N76394 001 Apr 25, 2003 Mar CRLD
>D> AP BEDFORD 50MG/ML N76018 001 Oct 15, 2002 Mar CRLD
>A> AP + 50MG/ML N76018 001 Oct 15, 2002 Mar CRLD
>D> AP BEDFORD LABS 50MG/ML N76299 001 Oct 24, 2002 Mar CRLD
>A> AP + 50MG/ML N76299 001 Oct 24, 2002 Mar CRLD
>D> AP BEN VENUE 50MG/ML N76088 001 Oct 15, 2002 Mar CRLD
>A> AP + 50MG/ML N76088 001 Oct 15, 2002 Mar CRLD
>D> AP BIONICHE (CANADA) 50MG/ML N76217 001 Oct 15, 2002 Mar CRLD
>A> AP + 50MG/ML N76217 001 Oct 15, 2002 Mar CRLD
>D> AP MAYNE PHARMA USA 50MG/ML N76108 001 Oct 15, 2002 Mar CRLD
>A> AP + MAYNE PHARMA USA 50MG/ML N76108 001 Oct 15, 2002 Mar CRLD
>D> AP SICOR PHARMS 50MG/ML N76163 001 Sep 05, 2003 Mar CRLD
>A> AP + 50MG/ML N76163 001 Sep 05, 2003 Mar CRLD
TABLET; ORAL
AMIODARONE HCL
>A> AB AUROSAL PHARMS 200MG N77069 001 Apr 08, 2005 Mar NEWA
>A> AB 400MG N77069 002 Apr 08, 2005 Mar NEWA
>D> AB COPLEY PHARM 200MG N74739 001 Nov 30, 1998 Mar CAHN
>D> TARO 100MG N75424 002 Dec 18, 2002 Mar CTEC
>A> AB 100MG N75424 002 Dec 18, 2002 Mar CTEC
>A> AB TEVA PHARMS 200MG N74739 001 Nov 30, 1998 Mar CAHN
PACERONE
>A> AB UPSHER SMITH 100MG N75135 002 Apr 12, 2005 Mar NEWA
ANAGRELIDE HYDROCHLORIDE
CAPSULE; ORAL
AGRYLIN
>D> SHIRE EQ 0.5MG BASE N20333 001 Mar 14, 1997 Mar CFTG
>A> AB EQ 0.5MG BASE N20333 001 Mar 14, 1997 Mar CFTG
>D> + EQ 1MG BASE N20333 002 Mar 14, 1997 Mar CFTG
>A> AB + EQ 1MG BASE N20333 002 Mar 14, 1997 Mar CFTG
>A> ANAGRELIDE HCL
>A> AB BARR EQ 0.5MG BASE N76530 001 Apr 18, 2005 Mar NEWA
>A> AB EQ 1MG BASE N76530 002 Apr 18, 2005 Mar NEWA
>A> AB EON EQ 0.5MG BASE N76683 001 Apr 18, 2005 Mar NEWA
>A> AB EQ 1MG BASE N76683 002 Apr 18, 2005 Mar NEWA
>A> AB IMPAX LABS EQ 0.5MG BASE N76910 001 Apr 18, 2005 Mar NEWA
>A> AB EQ 1MG BASE N76910 002 Apr 18, 2005 Mar NEWA
>A> AB IVAX PHARMS EQ 0.5MG BASE N76468 001 Apr 18, 2005 Mar NEWA
>A> AB EQ 1MG BASE N76468 002 Apr 18, 2005 Mar NEWA
>A> AB MYLAN EQ 0.5MG BASE N76811 001 Apr 18, 2005 Mar NEWA
>A> AB EQ 1MG BASE N76811 002 Apr 18, 2005 Mar NEWA
>A> AB ROXANE EQ 0.5MG BASE N76489 001 Apr 18, 2005 Mar NEWA
>A> AB EQ 1MG BASE N76489 002 Apr 18, 2005 Mar NEWA
>A> AB WATSON LABS EQ 0.5MG BASE N76417 001 Apr 18, 2005 Mar NEWA
>A> AB EQ 1MG BASE N76417 002 Apr 18, 2005 Mar NEWA
ATENOLOL
TABLET; ORAL
ATENOLOL
>D> AB COPLEY PHARM 50MG N74120 001 Feb 24, 1995 Mar CAHN
>D> AB 100MG N74120 002 Feb 24, 1995 Mar CAHN
>D> MYLAN 25MG N73457 002 Apr 26, 1999 Mar CTEC
>A> AB 25MG N73457 002 Apr 26, 1999 Mar CTEC
>A> AB TEVA PHARMS 50MG N74120 001 Feb 24, 1995 Mar CAHN
>A> AB 100MG N74120 002 Feb 24, 1995 Mar CAHN
>D> BENZYL PENICILLOYL-POLYLYSINE
>D> INJECTABLE; INJECTION
>D> PRE-PEN
>D> + HOLLISTER STIER 60UMOLAR N50114 001 Mar DISC
>A> @ 60UMOLAR N50114 001 Mar DISC
BETAMETHASONE DIPROPIONATE
LOTION; TOPICAL
BETAMETHASONE DIPROPIONATE
>D> AB COPLEY PHARM EQ 0.05% BASE N71882 001 Jun 06, 1988 Mar CAHN
>A> AB TEVA PHARMS EQ 0.05% BASE N71882 001 Jun 06, 1988 Mar CAHN
BETAMETHASONE VALERATE
LOTION; TOPICAL
BETAMETHASONE VALERATE
>D> AB COPLEY PHARM EQ 0.1% BASE N71883 001 Apr 22, 1988 Mar CAHN
>A> AB TEVA PHARMS EQ 0.1% BASE N71883 001 Apr 22, 1988 Mar CAHN
BISOPROLOL FUMARATE
TABLET; ORAL
BISOPROLOL FUMARATE
>D> AB COPLEY PHARM 5MG N75644 001 Jun 26, 2001 Mar CAHN
>D> AB COPLEY PHARM 10MG N75644 002 Jun 26, 2001 Mar CAHN
>A> AB TEVA PHARMS 5MG N75644 001 Jun 26, 2001 Mar CAHN
>A> AB 10MG N75644 002 Jun 26, 2001 Mar CAHN
>A> BROMFENAC SODIUM
>A> SOLUTION/DROPS; OPHTHALMIC
>A> XIBROM
>A> + ISTA PHARMS 0.09% N21664 001 Mar 24, 2005 Mar NEWA
BROMOCRIPTINE MESYLATE
CAPSULE; ORAL
BROMOCRIPTINE MESYLATE
>A> AB MYLAN EQ 5MG BASE N77226 001 Apr 04, 2005 Mar NEWA
PARLODEL
>D> + NOVARTIS EQ 5MG BASE N17962 002 Mar 01, 1982 Mar CTEC
>A> AB + EQ 5MG BASE N17962 002 Mar 01, 1982 Mar CTEC
CAPTOPRIL
TABLET; ORAL
CAPTOPRIL
>D> AB COPLEY PHARM 12.5MG N74462 001 Feb 13, 1996 Mar CAHN
>D> AB 25MG N74462 002 Feb 13, 1996 Mar CAHN
>D> AB 50MG N74462 003 Feb 13, 1996 Mar CAHN
>D> AB 100MG N74462 004 Feb 13, 1996 Mar CAHN
>A> AB TEVA PHARMS 12.5MG N74462 001 Feb 13, 1996 Mar CAHN
>A> AB 25MG N74462 002 Feb 13, 1996 Mar CAHN
>A> AB 50MG N74462 003 Feb 13, 1996 Mar CAHN
>A> AB 100MG N74462 004 Feb 13, 1996 Mar CAHN
CARBAMAZEPINE
SUSPENSION; ORAL
CARBAMAZEPINE
>D> AB TARO 100MG/5ML N75875 001 Dec 21, 2000 Mar DISC
>A> @ 100MG/5ML N75875 001 Dec 21, 2000 Mar DISC
CARBOPLATIN
INJECTABLE; INJECTION
CARBOPLATIN
>A> AP EON 50MG/VIAL N76959 001 Mar 18, 2005 Mar NEWA
>A> AP 150MG/VIAL N76959 002 Mar 18, 2005 Mar NEWA
>A> AP 450MG/VIAL N76959 003 Mar 18, 2005 Mar NEWA
CEFACLOR
CAPSULE; ORAL
>D> CECLOR
>D> AB LILLY EQ 250MG BASE N50521 001 Mar DISC
>A> @ EQ 250MG BASE N50521 001 Mar DISC
>D> AB + EQ 500MG BASE N50521 002 Mar DISC
>A> @ EQ 500MG BASE N50521 002 Mar DISC
CEFACLOR
>D> AB RANBAXY EQ 500MG BASE N64156 002 Aug 28, 1997 Mar CRLD
>A> AB + EQ 500MG BASE N64156 002 Aug 28, 1997 Mar CRLD
FOR SUSPENSION; ORAL
CECLOR
>D> AB + CEPH INTL EQ 375MG BASE/5ML N62206 004 Apr 20, 1988 Mar CRLD
>A> AB EQ 375MG BASE/5ML N62206 004 Apr 20, 1988 Mar CRLD
>D> AB LILLY EQ 125MG BASE/5ML N50522 001 Mar DISC
>A> @ EQ 125MG BASE/5ML N50522 001 Mar DISC
>D> AB + EQ 250MG BASE/5ML N50522 002 Mar DISC
>A> @ EQ 250MG BASE/5ML N50522 002 Mar DISC
CEFACLOR
>D> AB RANBAXY EQ 375MG BASE/5ML N64155 001 Oct 02, 1997 Mar CRLD
>A> AB + EQ 375MG BASE/5ML N64155 001 Oct 02, 1997 Mar CRLD
CEFAZOLIN SODIUM
INJECTABLE; INJECTION
CEFAZOLIN SODIUM
>D> AP AM PHARM PARTNERS EQ 500MG BASE/VIAL N64169 001 Aug 14, 1998 Mar CRLD
>A> AP + EQ 500MG BASE/VIAL N64169 001 Aug 14, 1998 Mar CRLD
>D> AP EQ 1GM BASE/VIAL N64169 002 Aug 14, 1998 Mar CRLD
>A> AP + AM PHARM PARTNERS EQ 1GM BASE/VIAL N64169 002 Aug 14, 1998 Mar CRLD
>D> AP EQ 10GM BASE/VIAL N64170 001 Mar 18, 1998 Mar CRLD
>A> AP + EQ 10GM BASE/VIAL N64170 001 Mar 18, 1998 Mar CRLD
CEPHALEXIN
CAPSULE; ORAL
CEPHALEXIN
>D> AB APOTHECON EQ 250MG BASE N63186 001 Dec 30, 1994 Mar DISC
>A> @ EQ 250MG BASE N63186 001 Dec 30, 1994 Mar DISC
>D> AB EQ 500MG BASE N63186 002 Dec 30, 1994 Mar DISC
>A> @ EQ 500MG BASE N63186 002 Dec 30, 1994 Mar DISC
CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX
SUSPENSION, EXTENDED RELEASE; ORAL
CODEPREX
>D> + CELLTECH PHARMS EQ 4MG MALEATE/5ML;EQ 20MG N21369 001 Jun 21, 2004 Mar CAHN
>A> + UCB EQ 4MG MALEATE/5ML;EQ 20MG N21369 001 Jun 21, 2004 Mar CAHN
CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX
SUSPENSION, EXTENDED RELEASE; ORAL
TUSSIONEX
>D> + CELLTECH PHARMS EQ 8MG MALEATE/5ML;EQ 10MG N19111 001 Dec 31, 1987 Mar CAHN
BITARTRATE/5ML
>A> + UCB EQ 8MG MALEATE/5ML;EQ 10MG N19111 001 Dec 31, 1987 Mar CAHN
BITARTRATE/5ML
CHOLESTYRAMINE
POWDER; ORAL
CHOLESTYRAMINE
>D> AB COPLEY PHARM EQ 4GM RESIN/PACKET N74554 001 Oct 02, 1996 Mar CAHN
>D> AB EQ 4GM RESIN/SCOOPFUL N74554 002 Oct 02, 1996 Mar CAHN
>A> AB TEVA PHARMS EQ 4GM RESIN/PACKET N74554 001 Oct 02, 1996 Mar CAHN
>A> AB EQ 4GM RESIN/SCOOPFUL N74554 002 Oct 02, 1996 Mar CAHN
CHOLESTYRAMINE LIGHT
>D> AB COPLEY PHARM EQ 4GM RESIN/PACKET N74555 001 Sep 30, 1998 Mar CAHN
>D> AB EQ 4GM RESIN/SCOOPFUL N74555 002 Sep 30, 1998 Mar CAHN
>A> AB TEVA PHARMS EQ 4GM RESIN/PACKET N74555 001 Sep 30, 1998 Mar CAHN
>A> AB EQ 4GM RESIN/SCOOPFUL N74555 002 Sep 30, 1998 Mar CAHN
CICLOPIROX
CREAM; TOPICAL
CICLOPIROX
>A> AB TARO 0.77% N76790 001 Apr 12, 2005 Mar NEWA
CIMETIDINE HYDROCHLORIDE
SOLUTION; ORAL
CIMETIDINE HCL
>D> AA COPLEY PHARM EQ 300MG BASE/5ML N74859 001 Jul 09, 1998 Mar CAHN
>A> AA TEVA PHARMS EQ 300MG BASE/5ML N74859 001 Jul 09, 1998 Mar CAHN
CLEMASTINE FUMARATE
SYRUP; ORAL
CLEMASTINE FUMARATE
>D> AA COPLEY PHARM EQ 0.5MG BASE/5ML N73095 001 Apr 21, 1992 Mar CAHN
>A> AA TEVA PHARMS EQ 0.5MG BASE/5ML N73095 001 Apr 21, 1992 Mar CAHN
CLINDAMYCIN PHOSPHATE
INJECTABLE; INJECTION
CLINDAMYCIN PHOSPHATE
>D> @ HOSPIRA EQ 150MG BASE/ML N62943 001 Sep 29, 1988 Mar CMFD
>A> AP EQ 150MG BASE/ML N62943 001 Sep 29, 1988 Mar CMFD
CLOBETASOL PROPIONATE
CREAM; TOPICAL
CLOBETASOL PROPIONATE
>D> AB1 COPLEY PHARM 0.05% N74087 001 Feb 16, 1994 Mar CAHN
>A> AB1 TEVA PHARMS 0.05% N74087 001 Feb 16, 1994 Mar CAHN
OINTMENT; TOPICAL
CLOBETASOL PROPIONATE
>D> AB COPLEY PHARM 0.05% N74089 001 Feb 16, 1994 Mar CAHN
>A> AB TEVA PHARMS 0.05% N74089 001 Feb 16, 1994 Mar CAHN
CROMOLYN SODIUM
SOLUTION, CONCENTRATE; ORAL
GASTROCROM
>D> + CELLTECH PHARMS 100MG/5ML N20479 001 Feb 29, 1996 Mar CAHN
>A> + UCB 100MG/5ML N20479 001 Feb 29, 1996 Mar CAHN
CYCLOSPORINE
CAPSULE; ORAL
CYCLOSPORINE
>A> AB1 IVAX PHARMS 25MG N65110 003 Mar 29, 2005 Mar NEWA
>A> AB1 50MG N65110 001 Mar 29, 2005 Mar NEWA
>A> AB1 100MG N65110 002 Mar 29, 2005 Mar NEWA
GENGRAF
>D> BX ABBOTT 50MG N65003 002 May 12, 2000 Mar CTEC
>A> AB1 50MG N65003 002 May 12, 2000 Mar CTEC
SOLUTION; ORAL
CYCLOSPORINE
>A> AB1 IVAX PHARMS 100MG/ML N65078 001 Mar 25, 2005 Mar NEWA
>D> DESIRUDIN
>D> INJECTABLE; SUBCUTANEOUS
>D> IPRIVASK
>D> + CANYON 15MG/VIAL N21271 001 Apr 04, 2003 Mar CAIN
>A> DESIRUDIN RECOMBINANT
>A> INJECTABLE; SUBCUTANEOUS
>A> IPRIVASK
>A> + CANYON 15MG/VIAL N21271 001 Apr 04, 2003 Mar CAIN
DESLORATADINE; PSEUDOEPHEDRINE SULFATE
>A> TABLET, EXTENDED RELEASE; ORAL
>A> CLARINEX D 24 HOUR
>A> + SCHERING 5MG;240MG N21605 001 Mar 03, 2005 Mar NEWA
DESONIDE
CREAM; TOPICAL
DESONIDE
>D> AB COPLEY PHARM 0.05% N74027 001 Sep 28, 1992 Mar CAHN
>A> AB TEVA PHARMS 0.05% N74027 001 Sep 28, 1992 Mar CAHN
DEXAMETHASONE
TABLET; ORAL
DEXAMETHASONE
>D> + PAR PHARM 0.25MG N88149 001 Apr 28, 1983 Mar CRLD
>A> 0.25MG N88149 001 Apr 28, 1983 Mar CRLD
>D> BP + ROXANE 1.5MG N84610 001 Mar CRLD
>A> BP 1.5MG N84610 001 Mar CRLD
DEXTROSE
INJECTABLE; INJECTION
DEXTROSE 50% IN PLASTIC CONTAINER
>D> @ HOSPIRA 500MG/ML N19445 001 Jun 03, 1986 Mar CMFD
>A> AP 500MG/ML N19445 001 Jun 03, 1986 Mar CMFD
DICLOFENAC SODIUM
TABLET, DELAYED RELEASE; ORAL
DICLOFENAC SODIUM
>D> AB COPLEY PHARM 25MG N74459 001 Jun 25, 1997 Mar CAHN
>D> AB 50MG N74459 002 Jun 25, 1997 Mar CAHN
>D> AB 75MG N74459 003 Jun 25, 1997 Mar CAHN
>A> AB TEVA PHARMS 25MG N74459 001 Jun 25, 1997 Mar CAHN
>A> AB 50MG N74459 002 Jun 25, 1997 Mar CAHN
>A> AB 75MG N74459 003 Jun 25, 1997 Mar CAHN
DICYCLOMINE HYDROCHLORIDE
SYRUP; ORAL
BENTYL
>D> + AXCAN SCANDIPHARM 10MG/5ML N07961 002 Oct 15, 1984 Mar CTEC
>A> AA + AXCAN SCANDIPHARM 10MG/5ML N07961 002 Oct 15, 1984 Mar CTEC
>A> DICYCLOMINE HCL
>A> AA MIKART 10MG/5ML N40169 001 Mar 24, 2005 Mar NEWA
DILTIAZEM HYDROCHLORIDE
INJECTABLE; INJECTION
CARDIZEM
>D> AP + BIOVAIL 5MG/ML N20027 001 Oct 24, 1991 Mar CAHN
>D> + 25MG/VIAL N20027 003 Aug 18, 1995 Mar CAHN
>A> AP + BIOVAIL LABS INTL 5MG/ML N20027 001 Oct 24, 1991 Mar CAHN
>A> + 25MG/VIAL N20027 003 Aug 18, 1995 Mar CAHN
TABLET, EXTENDED RELEASE; ORAL
CARDIZEM LA
>D> BIOVAIL 120MG N21392 001 Feb 06, 2003 Mar CAHN
>D> 180MG N21392 002 Feb 06, 2003 Mar CAHN
>D> 240MG N21392 003 Feb 06, 2003 Mar CAHN
>D> 300MG N21392 004 Feb 06, 2003 Mar CAHN
>D> 360MG N21392 005 Feb 06, 2003 Mar CAHN
>D> + 420MG N21392 006 Feb 06, 2003 Mar CAHN
>A> BIOVAIL LABS INTL 120MG N21392 001 Feb 06, 2003 Mar CAHN
>A> 180MG N21392 002 Feb 06, 2003 Mar CAHN
>A> 240MG N21392 003 Feb 06, 2003 Mar CAHN
>A> 300MG N21392 004 Feb 06, 2003 Mar CAHN
>A> 360MG N21392 005 Feb 06, 2003 Mar CAHN
>A> + 420MG N21392 006 Feb 06, 2003 Mar CAHN
TABLET; ORAL
CARDIZEM
>D> AB BIOVAIL 30MG N18602 001 Nov 05, 1982 Mar CAHN
>D> AB 60MG N18602 002 Nov 05, 1982 Mar CAHN
>D> AB 90MG N18602 003 Dec 08, 1986 Mar CAHN
>D> AB + 120MG N18602 004 Dec 08, 1986 Mar CAHN
>A> AB BIOVAIL LABS INTL 30MG N18602 001 Nov 05, 1982 Mar CAHN
>A> AB 60MG N18602 002 Nov 05, 1982 Mar CAHN
>A> AB 90MG N18602 003 Dec 08, 1986 Mar CAHN
>A> AB + 120MG N18602 004 Dec 08, 1986 Mar CAHN
DILTIAZEM HCL
>D> AB COPLEY PHARM 30MG N74067 001 Nov 05, 1992 Mar CAHN
>D> AB 60MG N74067 002 Nov 05, 1992 Mar CAHN
>D> AB 90MG N74067 003 Nov 05, 1992 Mar CAHN
>D> AB 120MG N74067 004 Nov 05, 1992 Mar CAHN
>A> AB TEVA PHARMS 30MG N74067 001 Nov 05, 1992 Mar CAHN
>A> AB 60MG N74067 002 Nov 05, 1992 Mar CAHN
>A> AB 90MG N74067 003 Nov 05, 1992 Mar CAHN
>A> AB 120MG N74067 004 Nov 05, 1992 Mar CAHN
DOXEPIN HYDROCHLORIDE
CONCENTRATE; ORAL
DOXEPIN HCL
>D> AA COPLEY PHARM EQ 10MG BASE/ML N71609 001 Nov 09, 1987 Mar CAHN
>A> AA TEVA PHARMS EQ 10MG BASE/ML N71609 001 Nov 09, 1987 Mar CAHN
DOXYCYCLINE
CAPSULE; ORAL
DOXYCYCLINE
>A> AB PAR PHARM EQ 75MG BASE N65055 004 Apr 18, 2005 Mar NEWA
>D> + RANBAXY EQ 75MG BASE N65053 003 Sep 10, 2003 Mar CTEC
>A> AB EQ 75MG BASE N65053 003 Sep 10, 2003 Mar CTEC
ENALAPRIL MALEATE
TABLET; ORAL
VASOTEC
>D> AB BIOVAIL 2.5MG N18998 005 Jul 26, 1988 Mar CAHN
>D> AB 5MG N18998 001 Dec 24, 1985 Mar CAHN
>D> AB 10MG N18998 002 Dec 24, 1985 Mar CAHN
>D> AB + 20MG N18998 003 Dec 24, 1985 Mar CAHN
>A> AB BIOVAIL LABS INTL 2.5MG N18998 005 Jul 26, 1988 Mar CAHN
>A> AB 5MG N18998 001 Dec 24, 1985 Mar CAHN
>A> AB 10MG N18998 002 Dec 24, 1985 Mar CAHN
>A> AB + 20MG N18998 003 Dec 24, 1985 Mar CAHN
ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE
TABLET; ORAL
VASERETIC
>D> AB BIOVAIL 5MG;12.5MG N19221 003 Jul 12, 1995 Mar CAHN
>D> AB + 10MG;25MG N19221 001 Oct 31, 1986 Mar CAHN
>A> AB BIOVAIL LABS INTL 5MG;12.5MG N19221 003 Jul 12, 1995 Mar CAHN
>A> AB + 10MG;25MG N19221 001 Oct 31, 1986 Mar CAHN
ENALAPRILAT
INJECTABLE; INJECTION
VASOTEC
>D> AP + BIOVAIL 1.25MG/ML N19309 001 Feb 09, 1988 Mar CAHN
>A> AP + BIOVAIL LABS INTL 1.25MG/ML N19309 001 Feb 09, 1988 Mar CAHN
>A> ENTECAVIR
>A> SOLUTION; ORAL
>A> BARACLUDE
>A> + BRISTOL MYERS 0.05MG/ML N21798 001 Mar 29, 2005 Mar NEWA
>A> TABLET; ORAL
>A> BARACLUDE
>A> BRISTOL MYERS 0.5MG N21797 001 Mar 29, 2005 Mar NEWA
>A> + 1MG N21797 002 Mar 29, 2005 Mar NEWA
>A> ESOMEPRAZOLE SODIUM
>A> INJECTABLE; INTRAVENOUS
>A> NEXIUM IV
>A> + ASTRAZENECA 20MG/VIAL N21689 001 Mar 31, 2005 Mar NEWA
>A> + 40MG/VIAL N21689 002 Mar 31, 2005 Mar NEWA
ESTROGENS, CONJUGATED SYNTHETIC B
>D> TABLET; ORAL
>D> ENJUVIA
>A> @ DURAMED 0.3MG N21443 001 Dec 20, 2004 Mar DISC
>A> @ 0.45MG N21443 002 Dec 20, 2004 Mar DISC
ETHINYL ESTRADIOL; NORETHINDRONE
TABLET; ORAL-21
NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)
>D> AB + WATSON LABS 0.035MG,0.035MG;0.5MG,1MG N71041 001 Sep 24, 1991 Mar CTEC
>A> + 0.035MG,0.035MG;0.5MG,1MG N71041 001 Sep 24, 1991 Mar CTEC
NORTREL 7/7/7
>D> AB BARR 0.035MG,0.035MG,0.035MG;0.5MG,0.75M N75478 001 Aug 30, 2002 Mar CTEC
G,1MG
>A> 0.035MG,0.035MG,0.035MG;0.5MG,0.75M N75478 001 Aug 30, 2002 Mar CTEC
G,1MG
TABLET; ORAL-28
NORETHINDRONE AND ETHINYL ESTRADIOL (7/14)
>D> AB WATSON LABS 0.035MG,0.035MG;0.5MG,1MG N71042 001 Sep 24, 1991 Mar CTEC
>A> 0.035MG,0.035MG;0.5MG,1MG N71042 001 Sep 24, 1991 Mar CTEC
ORTHO-NOVUM 10/11-28
>D> AB ORTHO MCNEIL 0.035MG,0.035MG;0.5MG,1MG N18354 002 Jan 11, 1982 Mar CRLD
>A> AB + 0.035MG,0.035MG;0.5MG,1MG N18354 002 Jan 11, 1982 Mar CRLD
OVCON-35
>D> AB + WARNER CHILCOTT 0.035MG;0.4MG N17716 001 Mar CRLD
>A> AB 0.035MG;0.4MG N17716 001 Mar CRLD
ETHOSUXIMIDE
SYRUP; ORAL
ETHOSUXIMIDE
>D> AA COPLEY PHARM 250MG/5ML N81306 001 Jul 30, 1993 Mar CAHN
>A> AA TEVA PHARMS 250MG/5ML N81306 001 Jul 30, 1993 Mar CAHN
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
ALLEGRA-D 12 HOUR
>D> + AVENTIS PHARMS 60MG;120MG N20786 001 Dec 24, 1997 Mar CFTG
>A> AB + 60MG;120MG N20786 001 Dec 24, 1997 Mar CFTG
>A> FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCL
>A> AB BARR 60MG;120MG N76236 001 Apr 14, 2005 Mar NEWA
FLUCONAZOLE
INJECTABLE; INJECTION
FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER
>A> AP APOTEX 200MG/100ML N76888 001 Mar 25, 2005 Mar NEWA
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>A> AP APOTEX 200MG/100ML N76889 001 Mar 25, 2005 Mar NEWA
FLUOCINONIDE
SOLUTION; TOPICAL
FLUOCINONIDE
>D> AT COPLEY PHARM 0.05% N72522 001 Sep 28, 1990 Mar CAHN
>A> AT TEVA PHARMS 0.05% N72522 001 Sep 28, 1990 Mar CAHN
FLUPHENAZINE HYDROCHLORIDE
CONCENTRATE; ORAL
FLUPHENAZINE HCL
>D> AA COPLEY PHARM 5MG/ML N73058 001 Aug 30, 1991 Mar CAHN
>A> AA TEVA PHARMS 5MG/ML N73058 001 Aug 30, 1991 Mar CAHN
ELIXIR; ORAL
FLUPHENAZINE HCL
>D> AA COPLEY PHARM 2.5MG/5ML N81310 001 Apr 29, 1993 Mar CAHN
>A> AA TEVA PHARMS 2.5MG/5ML N81310 001 Apr 29, 1993 Mar CAHN
FLUTICASONE PROPIONATE
>A> LOTION; TOPICAL
>A> CUTIVATE
>A> + GLAXOSMITHKLINE 0.05% N21152 001 Mar 31, 2005 Mar NEWA
FOSINOPRIL SODIUM
TABLET; ORAL
FOSINOPRIL SODIUM
>A> AB INVAGEN PHARMS 10MG N77222 001 Apr 20, 2005 Mar NEWA
>A> AB 20MG N77222 002 Apr 20, 2005 Mar NEWA
>A> AB 40MG N77222 003 Apr 20, 2005 Mar NEWA
GABAPENTIN
CAPSULE; ORAL
GABAPENTIN
>A> AB APOTEX 100MG N75360 001 Apr 06, 2005 Mar NEWA
>A> AB 300MG N75360 002 Apr 06, 2005 Mar NEWA
>A> AB 400MG N75360 003 Apr 06, 2005 Mar NEWA
>A> AB EON 100MG N75539 001 Apr 06, 2005 Mar NEWA
>A> AB 300MG N75539 002 Apr 06, 2005 Mar NEWA
>A> AB 400MG N75539 003 Apr 06, 2005 Mar NEWA
>A> AB IVAX PHARMS 100MG N75477 001 Mar 23, 2005 Mar NEWA
>A> AB 300MG N75477 002 Mar 23, 2005 Mar NEWA
>A> AB 400MG N75477 003 Mar 23, 2005 Mar NEWA
GATIFLOXACIN
INJECTABLE; INJECTION
TEQUIN
>D> + BRISTOL MYERS EQ 2MG /ML(200MG/100ML) N21062 001 Dec 17, 1999 Mar CPOT
>D> + EQ 2MG /ML(400MG/200ML) N21062 002 Dec 17, 1999 Mar CPOT
>D> + EQ 10MG /ML(400MG) N21062 004 Dec 17, 1999 Mar CPOT
>A> + 400MG/40ML(10MG/ML) N21062 004 Dec 17, 1999 Mar CPOT
TEQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
>A> + BRISTOL MYERS 200MG/100ML(2MG/ML) N21062 001 Dec 17, 1999 Mar CPOT
>A> + 400MG/200ML(2MG/ML) N21062 002 Dec 17, 1999 Mar CPOT
GUANABENZ ACETATE
TABLET; ORAL
GUANABENZ ACETATE
>D> AB COPLEY PHARM EQ 4MG BASE N74267 001 Jun 01, 1994 Mar CAHN
>D> AB EQ 8MG BASE N74267 002 Jun 01, 1994 Mar CAHN
>A> AB TEVA PHARMS EQ 4MG BASE N74267 001 Jun 01, 1994 Mar CAHN
>A> AB EQ 8MG BASE N74267 002 Jun 01, 1994 Mar CAHN
HALOPERIDOL LACTATE
CONCENTRATE; ORAL
HALOPERIDOL
>D> AA + COPLEY PHARM EQ 2MG BASE/ML N71617 001 Dec 01, 1988 Mar CAHN
>A> AA + TEVA PHARMS EQ 2MG BASE/ML N71617 001 Dec 01, 1988 Mar CAHN
HYDROCHLOROTHIAZIDE; IRBESARTAN
TABLET; ORAL
AVALIDE
>D> + SANOFI 12.5MG;300MG N20758 003 Aug 31, 1998 Mar CRLD
>A> 12.5MG;300MG N20758 003 Aug 31, 1998 Mar CRLD
>A> + 25MG;300MG N20758 004 Mar 15, 2005 Mar NEWA
HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE
TABLET; ORAL
>A> QUINAPRIL HCL AND HYDROCHLOROTHIAZIDE
>A> AB MYLAN 12.5MG;EQ 10MG BASE N77093 001 Mar 28, 2005 Mar NEWA
>A> AB 12.5MG;EQ 20MG BASE N77093 002 Mar 28, 2005 Mar NEWA
>A> AB 25MG;EQ 20MG BASE N77093 003 Mar 28, 2005 Mar NEWA
HYDROCHLOROTHIAZIDE; VALSARTAN
TABLET; ORAL
DIOVAN HCT
>D> + NOVARTIS 12.5MG;160MG N20818 002 Mar 06, 1998 Mar CRLD
>A> 12.5MG;160MG N20818 002 Mar 06, 1998 Mar CRLD
>D> 25MG;160MG N20818 003 Jan 17, 2002 Mar CRLD
>A> + 25MG;160MG N20818 003 Jan 17, 2002 Mar CRLD
HYDROCORTISONE
ENEMA; RECTAL
HYDROCORTISONE
>D> AB COPLEY PHARM 100MG/60ML N74171 001 May 27, 1994 Mar CAHN
>A> AB TEVA PHARMS 100MG/60ML N74171 001 May 27, 1994 Mar CAHN
HYDROCORTISONE VALERATE
CREAM; TOPICAL
HYDROCORTISONE VALERATE
>D> AB COPLEY PHARM 0.2% N74489 001 Aug 12, 1998 Mar CAHN
>A> AB TEVA PHARMS 0.2% N74489 001 Aug 12, 1998 Mar CAHN
HYDROXYCHLOROQUINE SULFATE
TABLET; ORAL
HYDROXYCHLOROQUINE SULFATE
>D> AB COPLEY PHARM 200MG N40081 001 Sep 30, 1994 Mar CAHN
>A> AB TEVA PHARMS 200MG N40081 001 Sep 30, 1994 Mar CAHN
HYDROXYPROGESTERONE CAPROATE
INJECTABLE; INJECTION
HYDROXYPROGESTERONE CAPROATE
>D> @ STERIS 125MG/ML N17439 001 Mar CAHN
>D> @ 250MG/ML N17439 002 Mar CAHN
>A> @ WATSON LABS 125MG/ML N17439 001 Mar CAHN
>A> @ 250MG/ML N17439 002 Mar CAHN
IBANDRONATE SODIUM
TABLET; ORAL
BONIVA
>A> ROCHE EQ 150MG BASE N21455 002 Mar 24, 2005 Mar NEWA
IRON SUCROSE
INJECTABLE; INTRAVENOUS
VENOFER
>D> + LUITPOLD EQ 20MG BASE/ML N21135 001 Nov 06, 2000 Mar CPOT
>A> + EQ 100MG BASE/5ML(EQ 20MG BASE/ML) N21135 001 Nov 06, 2000 Mar CPOT
>A> EQ 50MG BASE/2.5ML(EQ 20MG N21135 002 Mar 20, 2005 Mar NEWA
>A> EQ 75MG BASE/3.75ML(EQ 20MG N21135 003 Mar 29, 2005 Mar NEWA
ISRADIPINE
TABLET, EXTENDED RELEASE; ORAL
DYNACIRC CR
>D> + RELIANT PHARMS 5MG N20336 001 Jun 01, 1994 Mar CRLD
>A> 5MG N20336 001 Jun 01, 1994 Mar CRLD
KETOCONAZOLE
SHAMPOO; TOPICAL
KETOCONAZOLE
>A> AB QLT USA 2% N76942 001 Apr 11, 2005 Mar NEWA
LACTULOSE
SOLUTION; ORAL
EVALOSE
>D> AA COPLEY PHARM 10GM/15ML N73497 001 May 28, 1993 Mar CAHN
>A> AA TEVA PHARMS 10GM/15ML N73497 001 May 28, 1993 Mar CAHN
SOLUTION; ORAL, RECTAL
HEPTALAC
>D> AA COPLEY PHARM 10GM/15ML N73504 001 May 28, 1993 Mar CAHN
>A> AA TEVA PHARMS 10GM/15ML N73504 001 May 28, 1993 Mar CAHN
>D> LEPIRUDIN
>D> INJECTABLE; INJECTION
>D> REFLUDAN
>D> + BERLEX 50MG/VIAL N20807 001 Mar 06, 1998 Mar CAIN
>A> LEPIRUDIN RECOMBINANT
>A> INJECTABLE; INJECTION
>A> REFLUDAN
>A> + BERLEX 50MG/VIAL N20807 001 Mar 06, 1998 Mar CAIN
LEVALBUTEROL TARTRATE
>A> AEROSOL, METERED; INHALATION
>A> XOPENEX HFA
>A> + SEPRACOR EQ 0.045MG BASE/INH N21730 001 Mar 11, 2005 Mar NEWA
LEVOFLOXACIN
TABLET; ORAL
LEVAQUIN
>D> AB ORTHO MCNEIL 250MG N20634 001 Dec 20, 1996 Mar CTEC
>A> 250MG N20634 001 Dec 20, 1996 Mar CTEC
>D> AB 500MG N20634 002 Dec 20, 1996 Mar CTEC
>A> 500MG N20634 002 Dec 20, 1996 Mar CTEC
LIDOCAINE HYDROCHLORIDE
JELLY; TOPICAL
LIDOCAINE HCL
>D> AT COPLEY PHARM 2% N81318 001 Apr 29, 1993 Mar CAHN
>A> AT TEVA PHARMS 2% N81318 001 Apr 29, 1993 Mar CAHN
MEBENDAZOLE
TABLET, CHEWABLE; ORAL
MEBENDAZOLE
>D> AB COPLEY PHARM 100MG N73580 001 Jan 04, 1995 Mar CAHN
>A> AB TEVA PHARMS 100MG N73580 001 Jan 04, 1995 Mar CAHN
MEGESTROL ACETATE
SUSPENSION; ORAL
MEGESTROL ACETATE
>D> AB COPLEY PHARM 40MG/ML N75681 001 May 05, 2003 Mar CAHN
>A> AB TEVA PHARMS 40MG/ML N75681 001 May 05, 2003 Mar CAHN
METAPROTERENOL SULFATE
SYRUP; ORAL
METAPROTERENOL SULFATE
>D> @ COPLEY PHARM 10MG/5ML N73034 001 Aug 30, 1991 Mar CAHN
>A> @ TEVA PHARMS 10MG/5ML N73034 001 Aug 30, 1991 Mar CAHN
METFORMIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
METFORMIN HCL
>A> AB ANDRX PHARMS 750MG N76869 001 Apr 12, 2005 Mar NEWA
>A> AB PUREPAC PHARM 750MG N76878 001 Apr 13, 2005 Mar NEWA
>A> AB TEVA 750MG N76864 001 Apr 12, 2005 Mar NEWA
>A> AB ZYDUS PHARMS USA 500MG N77060 001 Apr 20, 2005 Mar NEWA
TABLET; ORAL
METFORMIN HCL
>A> AB ZYDUS PHARMS USA 500MG N77064 001 Apr 18, 2005 Mar NEWA
>A> AB 850MG N77064 002 Apr 18, 2005 Mar NEWA
>A> AB 1GM N77064 003 Apr 18, 2005 Mar NEWA
METHAZOLAMIDE
TABLET; ORAL
METHAZOLAMIDE
>D> AB COPLEY PHARM 25MG N40001 001 Jun 30, 1993 Mar CAHN
>D> AB 50MG N40001 002 Jun 30, 1993 Mar CAHN
>A> AB TEVA PHARMS 25MG N40001 001 Jun 30, 1993 Mar CAHN
>A> AB 50MG N40001 002 Jun 30, 1993 Mar CAHN
METOLAZONE
TABLET; ORAL
ZAROXOLYN
>D> AB CELLTECH PHARMS 2.5MG N17386 001 Mar CAHN
>D> AB + 5MG N17386 002 Mar CAHN
>D> AB + 10MG N17386 003 Mar CAHN
>A> AB UCB 2.5MG N17386 001 Mar CAHN
>A> AB + 5MG N17386 002 Mar CAHN
>A> AB + 10MG N17386 003 Mar CAHN
METOPROLOL TARTRATE
TABLET; ORAL
METOPROLOL TARTRATE
>D> AB COPLEY PHARM 50MG N74333 001 Jan 27, 1994 Mar CAHN
>D> AB 100MG N74333 002 Jan 27, 1994 Mar CAHN
>A> AB TEVA PHARMS 50MG N74333 001 Jan 27, 1994 Mar CAHN
>A> AB 100MG N74333 002 Jan 27, 1994 Mar CAHN
>A> MICAFUNGIN SODIUM
>A> INJECTABLE; IV (INFUSION)
>A> MYCAMINE
>A> + ASTELLAS 50MG/VIAL N21506 002 Mar 16, 2005 Mar NEWA
MIDAZOLAM HYDROCHLORIDE
INJECTABLE; INJECTION
MIDAZOLAM HCL
>D> @ HOSPIRA EQ 1MG BASE/ML N75293 001 Jun 20, 2000 Mar CMFD
>A> AP EQ 1MG BASE/ML N75293 001 Jun 20, 2000 Mar CMFD
>D> @ EQ 5MG BASE/ML N75293 002 Jun 20, 2000 Mar CMFD
>A> AP EQ 5MG BASE/ML N75293 002 Jun 20, 2000 Mar CMFD
MOMETASONE FUROATE
CREAM; TOPICAL
MOMETASONE FUROATE
>A> AB ALTANA 0.1% N76171 001 Apr 08, 2005 Mar NEWA
LOTION; TOPICAL
ELOCON
>D> + SCHERING 0.1% N19796 001 Mar 30, 1989 Mar CFTG
>A> AB + 0.1% N19796 001 Mar 30, 1989 Mar CFTG
>A> MOMETASONE FUROATE
>A> AB AGIS INDS 0.1% N77180 001 Apr 06, 2005 Mar NEWA
OINTMENT; TOPICAL
MOMETASONE FUROATE
>A> AB ALTANA 0.1% N77061 001 Mar 28, 2005 Mar NEWA
>A> POWDER; INHALATION
>A> ASMANEX TWISTHALER
>A> + SCHERING 0.22MG/INH N21067 001 Mar 30, 2005 Mar NEWA
MOMETASONE FUROATE MONOHYDRATE
SPRAY, METERED; NASAL
NASONEX
>D> + SCHERING PLOUGH EQ 0.05MG BASE/SPRAY N20762 001 Oct 01, 1997 Mar CAHN
>A> + SHIRE EQ 0.05MG BASE/SPRAY N20762 001 Oct 01, 1997 Mar CAHN
MORPHINE SULFATE
CAPSULE, EXTENDED RELEASE; ORAL
AVINZA
>D> BX + LIGAND 30MG N21260 001 Mar 20, 2002 Mar CRLD
>A> BX LIGAND 30MG N21260 001 Mar 20, 2002 Mar CRLD
>D> BX + 60MG N21260 002 Mar 20, 2002 Mar CRLD
>A> BX 60MG N21260 002 Mar 20, 2002 Mar CRLD
>D> + 90MG N21260 003 Mar 20, 2002 Mar CRLD
>A> 90MG N21260 003 Mar 20, 2002 Mar CRLD
KADIAN
>D> + ALPHARMA US 20MG N20616 001 Jul 03, 1996 Mar CRLD
>A> 20MG N20616 001 Jul 03, 1996 Mar CRLD
>D> BX + 30MG N20616 004 Mar 09, 2001 Mar CRLD
>A> BX 30MG N20616 004 Mar 09, 2001 Mar CRLD
>D> + 50MG N20616 002 Jul 03, 1996 Mar CRLD
>A> 50MG N20616 002 Jul 03, 1996 Mar CRLD
>D> BX + 60MG N20616 005 Mar 09, 2001 Mar CRLD
>A> BX 60MG N20616 005 Mar 09, 2001 Mar CRLD
NADOLOL
TABLET; ORAL
NADOLOL
>D> AB COPLEY PHARM 80MG N74368 001 Aug 31, 1994 Mar CAHN
>D> AB 120MG N74368 002 Aug 31, 1994 Mar CAHN
>D> AB 160MG N74368 003 Aug 31, 1994 Mar CAHN
>A> AB TEVA PHARMS 80MG N74368 001 Aug 31, 1994 Mar CAHN
>A> AB 120MG N74368 002 Aug 31, 1994 Mar CAHN
>A> AB 160MG N74368 003 Aug 31, 1994 Mar CAHN
NALOXONE HYDROCHLORIDE
INJECTABLE; INJECTION
NALOXONE HCL
>D> @ HOSPIRA 0.4MG/ML N70172 001 Sep 24, 1986 Mar CMFD
>A> AP 0.4MG/ML N70172 001 Sep 24, 1986 Mar CMFD
NAPROXEN
TABLET; ORAL
NAPROXEN
>D> AB COPLEY PHARM 250MG N74207 001 Dec 21, 1993 Mar CAHN
>D> AB 375MG N74207 002 Dec 21, 1993 Mar CAHN
>D> AB 500MG N74207 003 Dec 21, 1993 Mar CAHN
>A> AB TEVA PHARMS 250MG N74207 001 Dec 21, 1993 Mar CAHN
>A> AB 375MG N74207 002 Dec 21, 1993 Mar CAHN
>A> AB 500MG N74207 003 Dec 21, 1993 Mar CAHN
NAPROXEN SODIUM
TABLET; ORAL
NAPROXEN SODIUM
>D> AB COPLEY PHARM EQ 250MG BASE N74289 001 Jan 27, 1994 Mar CAHN
>D> AB EQ 500MG BASE N74289 002 Jan 27, 1994 Mar CAHN
>A> AB TEVA PHARMS EQ 250MG BASE N74289 001 Jan 27, 1994 Mar CAHN
>A> AB EQ 500MG BASE N74289 002 Jan 27, 1994 Mar CAHN
NIACIN
TABLET, EXTENDED RELEASE; ORAL
>A> NIACIN
>A> AB BARR 1GM N76250 001 Apr 14, 2005 Mar NEWA
NIASPAN
>D> + KOS 1GM N20381 004 Jul 28, 1997 Mar CFTG
>A> AB + 1GM N20381 004 Jul 28, 1997 Mar CFTG
NICARDIPINE HYDROCHLORIDE
INJECTABLE; INJECTION
CARDENE
>A> + ESP PHARMA 2.5MG/ML N19734 001 Jan 30, 1992 Mar CAHN
>D> + ROCHE PALO 2.5MG/ML N19734 001 Jan 30, 1992 Mar CAHN
NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE
CAPSULE; ORAL
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
>A> AB EON 75MG;25MG N77066 001 Apr 05, 2005 Mar NEWA
>A> AB RANBAXY 75MG;25MG N76951 001 Mar 30, 2005 Mar NEWA
OCTREOTIDE ACETATE
INJECTABLE; INJECTION
>A> OCTREOTIDE ACETATE
>A> AP BEDFORD EQ 0.2MG BASE/ML N76330 001 Apr 08, 2005 Mar NEWA
>A> AP EQ 1MG BASE/ML N76330 002 Apr 08, 2005 Mar NEWA
>A> OCTREOTIDE ACETATE (PRESERVATIVE FREE)
>A> AP BEDFORD EQ 0.05MG BASE/ML N76313 001 Mar 28, 2005 Mar NEWA
>A> AP EQ 0.1MG BASE/ML N76313 003 Mar 28, 2005 Mar NEWA
>A> AP EQ 0.5MG BASE/ML N76313 002 Mar 28, 2005 Mar NEWA
SANDOSTATIN
>D> + NOVARTIS EQ 0.05MG BASE/ML N19667 001 Oct 21, 1988 Mar CFTG
>A> AP + EQ 0.05MG BASE/ML N19667 001 Oct 21, 1988 Mar CFTG
>D> + EQ 0.1MG BASE/ML N19667 002 Oct 21, 1988 Mar CFTG
>A> AP + EQ 0.1MG BASE/ML N19667 002 Oct 21, 1988 Mar CFTG
>D> + EQ 0.2MG BASE/ML N19667 004 Jun 12, 1991 Mar CFTG
>A> AP + EQ 0.2MG BASE/ML N19667 004 Jun 12, 1991 Mar CFTG
>D> + EQ 0.5MG BASE/ML N19667 003 Oct 21, 1988 Mar CFTG
>A> AP + EQ 0.5MG BASE/ML N19667 003 Oct 21, 1988 Mar CFTG
>D> + EQ 1MG BASE/ML N19667 005 Jun 12, 1991 Mar CFTG
>A> AP + EQ 1MG BASE/ML N19667 005 Jun 12, 1991 Mar CFTG
OLSALAZINE SODIUM
CAPSULE; ORAL
DIPENTUM
>D> + CELLTECH PHARMS 250MG N19715 001 Jul 31, 1990 Mar CAHN
>A> + UCB 250MG N19715 001 Jul 31, 1990 Mar CAHN
OMEPRAZOLE
CAPSULE, DELAYED REL PELLETS; ORAL
PRILOSEC
>D> AB + ASTRAZENECA 40MG N19810 002 Jan 15, 1998 Mar CTEC
>A> 40MG N19810 002 Jan 15, 1998 Mar CTEC
OXALIPLATIN
INJECTABLE; IV (INFUSION)
ELOXATIN
>D> SANOFI 50MG/VIAL N21492 001 Aug 09, 2002 Mar CRLD
>A> + 50MG/VIAL N21492 001 Aug 09, 2002 Mar CRLD
PEMOLINE
TABLET, CHEWABLE; ORAL
PEMOLINE
>D> AB COPLEY PHARM 37.5MG N75555 001 Feb 18, 2000 Mar CAHN
>A> AB TEVA PHARMS 37.5MG N75555 001 Feb 18, 2000 Mar CAHN
TABLET; ORAL
PEMOLINE
>D> AB COPLEY PHARM 18.75MG N75030 003 Feb 22, 2000 Mar CAHN
>D> AB 37.5MG N75030 001 Jan 29, 1999 Mar CAHN
>D> AB 75MG N75030 002 Jan 29, 1999 Mar CAHN
>A> AB TEVA PHARMS 18.75MG N75030 003 Feb 22, 2000 Mar CAHN
>A> AB 37.5MG N75030 001 Jan 29, 1999 Mar CAHN
>A> AB 75MG N75030 002 Jan 29, 1999 Mar CAHN
PHENTERMINE HYDROCHLORIDE
TABLET; ORAL
PHENTERMINE HCL
>A> AA LANNETT 37.5MG N40555 001 Apr 15, 2005 Mar NEWA
PHENTERMINE RESIN COMPLEX
CAPSULE, EXTENDED RELEASE; ORAL
IONAMIN
>D> CELLTECH PHARMS EQ 15MG BASE N11613 004 Mar CAHN
>D> + EQ 30MG BASE N11613 002 Mar CAHN
>A> UCB EQ 15MG BASE N11613 004 Mar CAHN
>A> + EQ 30MG BASE N11613 002 Mar CAHN
PHENYTOIN SODIUM
INJECTABLE; INJECTION
PHENYTOIN
>D> + ELKINS SINN 50MG/ML N84307 001 Mar CTEC
>A> AP + ELKINS SINN 50MG/ML N84307 001 Mar CTEC
PHENYTOIN SODIUM
>D> @ HOSPIRA 50MG/ML N89744 001 Dec 18, 1987 Mar CMFD
>A> AP 50MG/ML N89744 001 Dec 18, 1987 Mar CMFD
>D> @ 50MG/ML N89521 001 Mar 17, 1987 Mar CMFD
>A> AP 50MG/ML N89521 001 Mar 17, 1987 Mar CMFD
PIROXICAM
CAPSULE; ORAL
PIROXICAM
>D> AB COPLEY PHARM 10MG N74103 001 Aug 28, 1992 Mar CAHN
>D> AB 20MG N74103 002 Aug 28, 1992 Mar CAHN
>A> AB TEVA PHARMS 10MG N74103 001 Aug 28, 1992 Mar CAHN
>A> AB 20MG N74103 002 Aug 28, 1992 Mar CAHN
POTASSIUM CHLORIDE
INJECTABLE; INJECTION
POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER
>D> @ HOSPIRA 14.9MG/ML N20161 005 Nov 30, 1992 Mar CMFD
>A> AP 14.9MG/ML N20161 005 Nov 30, 1992 Mar CMFD
>D> @ 745MG/100ML N20161 001 Nov 30, 1992 Mar CMFD
>A> AP 745MG/100ML N20161 001 Nov 30, 1992 Mar CMFD
POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER
>D> @ HOSPIRA 1.49GM/100ML N20161 002 Nov 30, 1992 Mar CMFD
>A> AP 1.49GM/100ML N20161 002 Nov 30, 1992 Mar CMFD
>A> PRAMLINTIDE ACETATE
>A> INJECTABLE; SUBCUTANEOUS
>A> SYMLIN
>A> + AMYLIN EQ 3MG BASE/5ML (EQ 0.6MG BASE/ML) N21332 001 Mar 16, 2005 Mar NEWA
PREDNISOLONE
SYRUP; ORAL
PREDNISOLONE
>D> AA COPLEY PHARM 15MG/5ML N40322 001 Jan 19, 2000 Mar CAHN
>A> AA TEVA PHARMS 15MG/5ML N40322 001 Jan 19, 2000 Mar CAHN
PREDNISOLONE SODIUM PHOSPHATE
SOLUTION; ORAL
PEDIAPRED
>D> AA + CELLTECH PHARMS EQ 5MG BASE/5ML N19157 001 May 28, 1986 Mar CAHN
>A> AA + UCB EQ 5MG BASE/5ML N19157 001 May 28, 1986 Mar CAHN
PROCHLORPERAZINE MALEATE
TABLET; ORAL
PROCHLORPERAZINE MALEATE
>D> AB COPLEY PHARM EQ 5MG BASE N40120 001 Jul 11, 1996 Mar CAHN
>D> AB EQ 10MG BASE N40120 002 Jul 11, 1996 Mar CAHN
>A> AB TEVA PHARMS EQ 5MG BASE N40120 001 Jul 11, 1996 Mar CAHN
>A> AB EQ 10MG BASE N40120 002 Jul 11, 1996 Mar CAHN
PROPOFOL
INJECTABLE; INJECTION
PROPOFOL
>A> AB BEDFORD 10MG/ML N74848 001 Apr 19, 2005 Mar NEWA
QUINIDINE SULFATE
TABLET, EXTENDED RELEASE; ORAL
QUINIDINE SULFATE
>D> + COPLEY PHARM 300MG N40045 001 Jun 30, 1994 Mar CAHN
>A> + TEVA PHARMS 300MG N40045 001 Jun 30, 1994 Mar CAHN
SODIUM CHLORIDE
SOLUTION; IRRIGATION
SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
>D> @ HOSPIRA 450MG/100ML N18380 001 Mar CMFD
>A> AT 450MG/100ML N18380 001 Mar CMFD
>D> SOMATREM
>D> INJECTABLE; INJECTION
>D> PROTROPIN
>D> + GENENTECH 5MG/VIAL N19107 001 Oct 17, 1985 Mar DISC
>A> @ 5MG/VIAL N19107 001 Oct 17, 1985 Mar DISC
>D> + 10MG/VIAL N19107 002 Oct 24, 1989 Mar DISC
>A> @ 10MG/VIAL N19107 002 Oct 24, 1989 Mar DISC
TERBUTALINE SULFATE
TABLET; ORAL
TERBUTALINE SULFATE
>A> AB LANNETT 2.5MG N77152 001 Mar 25, 2005 Mar NEWA
>A> AB 5MG N77152 002 Mar 25, 2005 Mar NEWA
TETRACYCLINE HYDROCHLORIDE
CAPSULE; ORAL
>D> SUMYCIN
>D> AB APOTHECON 250MG N60429 001 Mar DISC
>A> @ 250MG N60429 001 Mar DISC
>D> AB + 500MG N60429 003 Mar DISC
>A> @ 500MG N60429 003 Mar DISC
TETRACYCLINE HCL
>D> AB IVAX PHARMS 500MG N60704 002 Mar CRLD
>A> AB + 500MG N60704 002 Mar CRLD
THIORIDAZINE HYDROCHLORIDE
CONCENTRATE; ORAL
THIORIDAZINE HCL
>D> AA + COPLEY PHARM 30MG/ML N89602 001 Nov 09, 1987 Mar CAHN
>D> AA + 100MG/ML N89603 001 Nov 09, 1987 Mar CAHN
>A> AA + TEVA PHARMS 30MG/ML N89602 001 Nov 09, 1987 Mar CAHN
>A> AA + 100MG/ML N89603 001 Nov 09, 1987 Mar CAHN
THIOTHIXENE HYDROCHLORIDE
CONCENTRATE; ORAL
THIOTHIXENE HCL
>D> AA COPLEY PHARM EQ 5MG BASE/ML N71554 001 Oct 16, 1987 Mar CAHN
>A> AA TEVA PHARMS EQ 5MG BASE/ML N71554 001 Oct 16, 1987 Mar CAHN
TRETINOIN
SOLUTION; TOPICAL
TRETINOIN
>D> AT COPLEY PHARM 0.05% N74873 001 Jun 19, 1998 Mar CAHN
>A> AT TEVA PHARMS 0.05% N74873 001 Jun 19, 1998 Mar CAHN
URSODIOL
CAPSULE; ORAL
URSODIOL
>D> AB COPLEY PHARM 300MG N75592 001 May 25, 2000 Mar CAHN
>A> AB TEVA PHARMS 300MG N75592 001 May 25, 2000 Mar CAHN
VALPROIC ACID
SYRUP; ORAL
VALPROIC ACID
>D> AA COPLEY PHARM 250MG/5ML N73178 001 Aug 25, 1992 Mar CAHN
>A> AA TEVA PHARMS 250MG/5ML N73178 001 Aug 25, 1992 Mar CAHN
VERAPAMIL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
VERELAN PM
>D> + ELAN PHARM 100MG N20943 001 Nov 25, 1998 Mar CRLD
>A> 100MG N20943 001 Nov 25, 1998 Mar CRLD
>D> + 200MG N20943 002 Nov 25, 1998 Mar CRLD
>A> 200MG N20943 002 Nov 25, 1998 Mar CRLD
VINORELBINE TARTRATE
INJECTABLE; INJECTION
VINORELBINE TARTRATE
>A> AP AM PHARM EQ 10MG BASE/ML N76849 001 Apr 18, 2005 Mar NEWA
ASPIRIN
TABLET; ORAL
BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN
>D> @ BAYER 500MG N21317 001 Oct 18, 2001 Mar CMFD
>A> 500MG N21317 001 Oct 18, 2001 Mar CMFD
CLOTRIMAZOLE
TABLET; VAGINAL
GYNIX
>D> COPLEY PHARM 100MG N73249 001 Feb 13, 1998 Mar CAHN
>A> TEVA PHARMS 100MG N73249 001 Feb 13, 1998 Mar CAHN
FAMOTIDINE
TABLET; ORAL
FAMOTIDINE
>A> PERRIGO 10MG N75400 001 Mar 18, 2005 Mar NEWA
 Back
to Top 
Index Page
Date Created: April 22, 2005 |
|
